Fulcrum Therapeutics, Inc. (FULC) has 10 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $1.5M, and 1 sales totalling $66K. Most recent filing: July 20, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 20, 2026 filed July 16, 2026 | TANG KEVIN 10% Owner | +$594,675 | 167,616 | +2% | No | |
|
|
||||||
| July 15, 2026 filed July 13, 2026 | TANG KEVIN 10% Owner | +$891,067 | 249,946 | +4% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Dorton Katina Director | $0 | 32,000 | 0% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Gould Robert J Director | $0 | 32,000 | 0% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Haviland Kate Director | $0 | 32,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free